|
2026
|
Invention
|
Fc region variant.
A polypeptide containing an antibody Fc region variant which has an amino aci... |
|
|
Invention
|
Image processing system, image processing method, image processing program, and image processing ... |
|
|
Invention
|
Anti-dengue virus antibodies, polypeptides containing variant fc regions, and methods of use.
Th... |
|
|
Invention
|
Antigen-binding molecule for promoting disappearance of antigen via fc gamma riib.
The present i... |
|
|
Invention
|
Polypeptide modification method for purifying polypeptide multimers.
The present invention provi... |
|
|
Invention
|
Cxcr3 ligand.
The present disclosure relates to CXCR3 ligands having resistance to DPPIV and hav... |
|
|
Invention
|
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly.
An obj... |
|
|
Invention
|
Cross-species anti-latent tgf-beta 1 antibodies and methods of use.
The present invention provid... |
|
|
Invention
|
Modified antibody constant region.
The present inventors succeeded in improving the antibody con... |
|
|
Invention
|
Method for controlling translation of rna. The present invention provides an RNA molecule compris... |
|
|
Invention
|
Antibody formulation. In one aspect, the present disclosure provides formulations, pharmaceutical... |
|
|
Invention
|
Pharmaceutical composition containing poorly-soluble basic medicine.
The present invention aims ... |
|
|
Invention
|
Antibody-containing formulation.
In one non-limiting embodiment, the present disclosure is an an... |
|
|
Invention
|
Antibodies and compositions for use in detecting or capturing a polypeptide in a sample, and meth... |
|
|
Invention
|
Anti-hla-dq2.5 antibody.
The antibodies of the present invention have specific binding activity ... |
|
|
Invention
|
Genetically modified non-human animal. The present invention provides a genetically modified non-... |
|
2025
|
Invention
|
Rna molecule for use in controlled translation. The present invention provides an RNA molecule co... |
|
|
Invention
|
Medicine for treating or preventing cancer. The present invention provides a medicine for treatin... |
|
|
Invention
|
Composition containing cyclic peptide and ursodeoxycholic acid. The present invention relates to ... |
|
|
Invention
|
Antibody substituting for function of blood coagulation factor viii.
The present inventors produ... |
|
|
Invention
|
Human syncytin-1 fusion protein and use thereof for target cell-specific cargo delivery. The pres... |
|
|
Invention
|
Antigen-binding molecule containing modified fc region.
The present inventors have successfully ... |
|
|
Invention
|
Method for screening peptide capable of binding to target molecule. The present invention relates... |
|
|
Invention
|
Recombinantly-engineered vertebrate cell. Provided is a recombinantly-engineered vertebrate cell ... |
|
|
Invention
|
Treatment of chronic pruritus with unknown origin. The present disclosure provides pharmaceutical... |
|
|
Invention
|
Method for quantifying unprotected amino acid in amino acid raw material. The present invention r... |
|
|
Invention
|
Antibodies binding to psi domain of integrin β6, and therapeutic method using same. The present i... |
|
|
Invention
|
Composition for treating il-6-related diseases.
The present invention provides a pharmaceutical ... |
|
|
Invention
|
Peptide proposal system, peptide proposal method, peptide proposal program, and peptide producing... |
|
|
Invention
|
One-armed antibody targeting kidney and not forming s-s bond in hinge region. One aspect of the p... |
|
|
Invention
|
Antigen-binding molecule, a pharmaceutical composition, and a method.
The present invention rela... |
|
|
Invention
|
Method for screening molecules of interest capable of forming complexes with plurality of types o... |
|
|
Invention
|
Lyophilized formulation sealed in glass container.
The present invention provides a lyophilized ... |
|
2024
|
Invention
|
Method for producing antibodies. A method for generating a cell that produces a multispecific bin... |
|
|
Invention
|
Genetically engineered vertebrate cell. Provided is a genetically engineered vertebrate cell for ... |
|
|
Invention
|
Peptide proposal system, peptide proposal method, peptide proposal program, and method for manufa... |
|
|
Invention
|
Conditionally activated receptor signaling by using scaffold protein.
The present invention rela... |
|
|
G/S
|
Pharmaceutical preparations. Providing education and training services in the medical
field. Pro... |
|
2023
|
Invention
|
Polypeptide with controlled association.
The present disclosure relates to polypeptides for whic... |
|
|
Invention
|
Purification method and production method of cyclic peptide.
A purification method of a cyclic p... |
|
|
Invention
|
A polypeptide complex whose antigen-binding activity varies depending on the concentration of a p... |
|
|
Invention
|
Process to make glp1 ra and intermediates therefor.
The present invention relates to the synthes... |
|
|
Invention
|
Peptide production method comprising step for translating amino acid having oxygen atom at specif... |
|
|
Invention
|
Work instruction device.
A robot system including mobile manipulators each including a local con... |
|
|
Invention
|
Method for producing cyclic peptide crystals.
There is disclosed a method for producing cyclic p... |
|
|
Invention
|
Method for producing n-substituted amino acid residue-containing cyclic peptide compound.
It has... |
|
|
Invention
|
Method for producing o-substituted serine derivative.
An object is to provide a method for produ... |
|
|
Invention
|
Combination drug.
The present invention relates to a drug for treating or preventing ALK fusion ... |
|
|
Invention
|
Methods of modifying antibodies for purification of bispecific antibodies. The present inventors ... |
|
2022
|
Invention
|
Syrup preparation.
The present invention relates to a syrup containing alectinib or a salt there... |
|
|
Invention
|
Pharmaceutical composition comprising anti-pd-l1 antibody used in combination with anti-vegf anti... |
|
2021
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical research and development services and providing information about medical and scie... |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or ... |
|
2020
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives, cells or genes tha... |
|
2019
|
G/S
|
Pharmaceutical research and development services and
providing information about medical and sci... |
|
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives; cells or genes tha... |
|
2017
|
G/S
|
Providing educational classes, seminars, workshops, symposiums and conferences and training servi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of hemophilia A. |
|
|
G/S
|
[ Pharmaceutical oncology preparations ] Providing educational classes, seminars, workshops, symp... |
|
|
G/S
|
pharmaceutical preparations for the treatment of Hemophilia A |
|
2013
|
G/S
|
pharmaceutical preparation, namely, an anti-cancer drug |
|
2012
|
G/S
|
Injection devices for medical purposes. |
|
|
G/S
|
injection devices for medical purposes |
|
2003
|
G/S
|
PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INTERLEUKIN-6 (IL-6) RECEPTOR MONOCLONAL ANTIBODY FOR T... |
|
|
G/S
|
Medicines for human purposes. |
|
2001
|
G/S
|
Pharmaceutical products. |
